Nucleic Acid Based Gene Therapy Market 2022 - By Nucleic Acid Technology (Anti-Sense and Anti-Gene Oligonucleotides, siRNA and RNA Interference, Gene Transfer Therapy, Ribozymes, Aptamers), By Application (Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases), By End User (Hospitals And Clinics, Academic And Research Institutes), And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $5000.00 | Pages : 222 | Published : January 2022 | | Format : pdf

Purchase Options
Request Sample
Request For Discount

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Nucleic Acid Based Gene Therapy Market Definition

The nucleic acid-based gene therapy market consists of sales of nucleic acid-based gene therapy products and services. Gene therapy is used for correcting defective genes that are responsible for disease development. Nucleic acid therapies are highly specific and long-lasting compared to the conventional therapies which are generally transient and have low specificity. Nucleic acid-based therapy either uses unmodified DNA or RNA or closely related compounds. Nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there is no permanent cure such as anemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.

Gene therapy is a technique, which modifies genes to treat or prevent diseases. Genes are the basic physical and functional unit of heredity, received from one’s parents. Genes act as a code for the creation of all proteins in a living organism. Gene therapy seeks to manipulate a patient’s cells to alter the biological property of cells for the treatment of an inherited or acquired disease. It works by several mechanisms, including replacing a disease-causing gene with a healthy copy of the gene, inactivating an ill-functioning disease-causing gene, or introducing a modified gene into the body to treat diseases.

Nucleic Acid Based Gene Therapy Market Size

The global nucleic acid-based gene therapy market grew from $1,391.9 million in 2015 to $4,726.8 million in 2020 at a compound annual growth rate (CAGR) of 27.7%. The nucleic acid-based gene therapy market is expected to grow from $4,726.8 million in 2020 to $7,282.9 million in 2025 at a rate of 9.0%. The nucleic acid-based gene therapy market is then expected to grow at a CAGR of 15.4% from 2025 and reach $14,909.6 million in 2030.  

Growth in the historic period in the nucleic acid-based gene therapy market resulted from technological advances in synthetic biology, advances in combinatorial chemistry and bioinformatics, increased healthcare expenditure, rising pharmaceutical R&D expenditure, and rise in public-private partnerships. The nucleic acid-based gene therapy market was restrained by off-target specificity, challenges in nucleotide delivery to cells, instability of the nucleotides, inadequate reimbursements, challenges due to regulatory changes, low healthcare access, and limited number of treatment centers.

Going forward rise in healthcare expenditure, increasing prevalence of cancer and chronic diseases, rising geriatric population, rising geriatric population, increasing research and development spending and rising focus on gene therapy will drive the growth in the nucleic acid-based gene therapy market. Factors that could hinder the growth of the nucleic acid-based gene therapy market in the future include high costs of therapy, stringent regulations, reimbursement challenges, and coronavirus pandemic.

Nucleic Acid Based Gene Therapy Market Drivers

The key drivers of the nucleic acid based gene therapy market include:

Rise In Healthcare Expenditure

Increasing healthcare expenditure is predicted to upsurge the demand for the nucleic acid-based gene therapy market. The growth in healthcare expenditure is aiding governments and organizations to spend more on prescription drugs, hospitals, and physical & clinical services, thereby driving the nucleic acid-based gene therapy market. According to the National Health Expenditure Projections 2018-2027, national healthcare expenditure is expected to reach nearly $6.0 trillion by 2027 in the USA, growing at an average rate of 5.5% annually from 2018 to 2027. Furthermore, prescription drug spending is projected to grow by 6.1% annually during 2020-2027.  Also, in terms of annual spending on approved gene therapies, it has reached $5.15 billion in 2020, and will increase to $25.3 billion by 2026.  Thus, the rise in healthcare spending is to increase the market for nucleic acid-based gene therapy in the near future.

Nucleic Acid Based Gene Therapy Market Restraints

The key restraints on the nucleic acid based gene therapy market include:

High Costs Of Therapy

High costs associated with nucleic acid-based gene therapy is a major issue faced by citizens of many countries. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective therapies for cancer has influenced the health conditions of the population and has led to a low average life expectancy. Thus, the high cost of therapy is restraining the growth of the nucleic acid-based gene therapy market.

Nucleic Acid Based Gene Therapy Market Trends

Major trends influencing the nucleic acid based gene therapy market include:

Global Research Initiatives And Funding

Pharmaceutical companies and federal governments are increasingly working together in partnerships and collaborations to provide funding and implement incentive programs for the research and development (R&D) of gene therapy. These partnerships provide financial and technical assistance across different clinical development phases to pharmaceutical companies. For instance, in 2020, The University of Bristol has secured a £45 million (US$ 61 million) to spin-out Purespring Therapeutics from Syncona Ltd for its gene therapy technology for chronic kidney disease.  In October 2019, the National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation pledge to invest $200 million over the next four years to speed the development of affordable gene therapies for human immunodeficiency virus (HIV) and sickle cell disease (SCD) on a global scale.

Integration Of Advanced Technologies In Gene Therapy

Major players operating in the nucleic acid-based gene therapy market are continuously collaborating or partnering with technology companies to integrate advanced technologies for the improvement of gene therapy. Advanced technologies such as artificial intelligence (AI) and big data are used for personalizing and manufacturing improved gene therapy. Machine Learning enables accelerated analysis of the sequenced data and enables effective prediction of the genetic alterations associated with a disease. This helps in reducing the time and effort required in the process of developing precision medicine. For instance, in September 2021, Mila, a Canada-based artificial intelligence research institute has partnered with Deep Genomics, a therapeutic artificial intelligence treatments provider. The partnership is to join the Mila community and take advantage of the recruitment services offered by the research institute.  In July 2021, I-Mab Biopharma Co. Ltd., China-based biotechnology company collaborated with Immorna Biotechnology Co. Ltd., a mRNA biotech company and Neox Biotech Co. Ltd., an Artificial Intelligence-enabled research & development company for gaining access to transformative technologies to innovate and develop oncology therapeutics.

Opportunities And Recommendations In The Nucleic Acid Based Gene Therapy Market

Opportunities –The top opportunities in the nucleic acid-based gene therapy market segmented by technology will arise in the anti-sense and anti-gene oligonucleotides segment, which will gain $1,290.7 million of global annual sales by 2025. The top opportunities in the nucleic-acid based gene therapy market segmented by application will arise in the muscular dystrophy/muscular disorders segment, which will gain $1,000.2 million of global annual sales by 2025. The top opportunities in the nucleic-acid based gene therapy market segmented by application will arise in the hospitals and clinics segment, which will gain $2,133.7 million of global annual sales by 2025. The nucleic acid-based gene therapy market size will gain the most in the USA at $915.0 million .

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the nucleic acid-based gene therapy companies to focus on partnerships and acquisitions, focus on gene editing, expanding in emerging markets, scale up through collaborations, offer competitive pricing, participate in gene therapy seminars and conferences and to focus on collaborating with hospitals.

Nucleic Acid Based Gene Therapy Market Segmentation

Nucleic acid based gene therapy market is segmented by nucleic acid technology into:
By Nucleic Acid Technology –
The nucleic acid based gene therapy market is segmented by nucleic acid technology into
    • a) Anti-Sense and Anti-Gene Oligonucleotides
    • b) siRNA and RNA Interference
    • c) Gene Transfer Therapy
    • d) Ribozymes
    • e) Aptamers
    • f) Others
The anti-sense and anti-gene oligonucleotides market was the largest segment of the nucleic acid-based gene therapy market segmented by technology, accounting for 92.90% of the total in 2020. Going forward, the others segment is expected to be the fastest growing segment in the nucleic acid-based gene therapy market segmented by technology, at a CAGR of 59.9% during 2020-2025.
By Application –
The nucleic acid based gene therapy market is segmented by application into
    • a) Oncology
    • b) Muscular Dystrophy/ Muscular Disorders
    • c) Rare Diseases
    • d) Others
The muscular dystrophy/muscular disorders market was the largest segment of the nucleic acid-based gene therapy market segmented by application, accounting for 61.4% of the total in 2020. Going forward, the oncology segment is expected to be the fastest growing segment in the nucleic-acid based gene therapy market segmented by application, at a CAGR of 18.1% during 2020-2025.
By End User –
The nucleic acid based gene therapy market is segmented by end user into
    • a) Hospitals And Clinics
    • b) Academic And Research Institutes
The hospitals and clinics market was the largest segment of the nucleic acid-based gene therapy market segmented by end-user, accounting for 85.0% of the total in 2020. Going forward, the academic and research institutes segment is expected to be the fastest growing segment in the nucleic-acid based gene therapy market segmented by end-user, at a CAGR of 9.8% during 2020-2025.
By Geography -
The nucleic acid based gene therapy market is segmented by geography into
      o North America
      • • USA
      o Western Europe
      • • UK
      • • Germany
      • • France
      o Asia Pacific
      • China
      • India
      • Australia
      • Indonesia
      • Japan
      • South Korea
      o Eastern Europe
      • • Russia
      o South America
      • • Brazil
      o Middle East
      o Africa
North America was the largest region in the global nucleic acid-based gene therapy market, accounting for 46.2% of the total in 2020. It was followed by the Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the nucleic acid-based gene therapy market will be the Middle East and Eastern Europe where growth will be at CAGRs of 33.7% and 26.0% respectively. These will be followed by South America and Asia Pacific, where the markets are expected to register CAGRs of 21.0% and 20.4% respectively.

Nucleic Acid Based Gene Therapy Competitive Landscape

Major Competitors Are:

  • Copernicus Therapeutics
  • Moderna Inc.
  • Wave Life Sciences
  • Protagonist Therapeutics
  • Transgene

    • Other Competitors Include:

  • uniQure NV
  • Sarepta Therapeutics Inc.
  • Oxford Biomedica
  • Benitec Biopharma
  • PYC Therapeutics Limited
  • Imugene Ltd
  • Benitec Biopharma Ltd
  • EdiGene, Inc.
  • GenScript
  • Biomics Biotechnologies (Nantong) Co., Ltd.
  • Auris Medical Holding Ltd
  • Akcea Therapeutics
  • Arctoris Limited
  • BioNTech SE
  • Freeline Therapeutics
  • Celyad Oncology
  • Cellectis
  • Celgene Corporation
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd
  • Eli Lilly and Company
  • Pfizer
  • AstraZeneca
  • Bayer AG
  • Voyager Therapeutics Inc.
  • Roche Holding AG
  • Gilead Sciences, Inc.
  • Amgen Brasil
  • Biogen Brazil
  • Novartis
  • Middle East Gene Therapy Company
  • DEVA
  • Biotchpharma
  • Gene Vector Technologies
  • BrainStorm Cell Therapeutics
  • Pluristem
  • Merck
  • Sanofi
  • Adcock Ingram

      • Table Of Contents

      1. Nucleic Acid Based Gene Therapy Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1. Segmentation By Geography

      6.2. Segmentation By Technology

      6.3. Segmentation By Application

      6.4. Segmentation By End-User

      7. Nucleic Acid Based Gene Therapy Market Characteristics

      7.1. Market Definition

      7.2. Segmentation By Nucleic Acid Technology

      7.2.1. Anti-Sense and Anti-Gene Oligonucleotides

      7.2.2. siRNA and RNA Interference

      7.2.3. Gene Transfer Therapy

      7.2.4. Ribozymes

      7.2.5. Aptamers

      7.2.6. Others

      7.3. Segmentation By Application

      7.3.1. Oncology

      7.3.2. Muscular Dystrophy/ Muscular Disorders

      7.3.3. Rare Diseases

      7.3.4. Others

      7.4. Segmentation By End-User

      7.4.1. Hospitals And Clinics

      7.4.2. Academic And Research Institutes

      8. Nucleic Acid Based Gene Therapy Market Trends And Strategies

      8.1. Global Research Initiatives And Funding

      8.2. Integration Of Advanced Technologies In Gene Therapy

      8.3. Increasing Partnerships And Acquisitions For Promoting Gene Therapy

      8.4. Increasing Number Of Pipeline Studies And Drug Development

      8.5. Growing Investments and Manufacturing Facility Expansion

      8.6. Rising Focus On Gene Editing

      9. Impact Of COVID-19 On The Nucleic Acid Based Gene Therapy Market

      9.1. Introduction

      9.2. Supply Chain Disruptions

      9.3. Impact On Clinical Trials

      9.4. Impact on Manufacturers and Activities

      9.5. Conclusion

      10. Global Nucleic Acid Based Gene Therapy Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

      10.2.1. Drivers Of The Market 2015 – 2020

      10.2.2. Restraints On The Market 2015 – 2020

      10.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      10.3.1. Drivers Of The Market 2020 – 2025

      10.3.2. Restraints On The Market 2020 – 2025

      11. Global Nucleic Acid Based Gene Therapy Market Segmentation

      11.1. Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.2. Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.3. Global Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12. Nucleic Acid Based Gene Therapy Market, Regional And Country Analysis

      12.1. Global Nucleic Acid Based Gene Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12.2. Global Nucleic Acid Based Gene Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13. Asia-Pacific Nucleic Acid Based Gene Therapy Market

      13.1. Asia-Pacific Nucleic Acid Based Gene Therapy Market Overview

      13.1.1. Region Information

      13.1.2. Market Information

      13.1.3. Background Information

      13.1.4. Government Initiatives

      13.1.5. Regulations

      13.1.6. Regulatory Bodies

      13.1.7. Major Associations

      13.1.8. Taxes Levied

      13.1.9. Corporate Tax Structure

      13.1.10. Investments

      13.1.11. Major Companies

      13.2. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.3. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.4. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.5. Asia-Pacific Nucleic Acid Based Gene Therapy Market: Country Analysis

      13.6. China Nucleic Acid Based Gene Therapy Market

      13.7. China Nucleic Acid Based Gene Therapy Market Overview

      13.7.1. Country Information

      13.7.2. Market Information

      13.7.3. Background Information

      13.7.4. Government Initiatives

      13.7.5. Regulations

      13.7.6. Regulatory Bodies

      13.7.7. Major Associations

      13.7.8. Taxes Levied

      13.7.9. Corporate Tax Structure

      13.7.10. Investments

      13.7.11. Major Companies

      13.8. China Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.9. China Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.10. China Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.11.  India Nucleic Acid Based Gene Therapy Market

      13.12. India Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.13.  India Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.14. India Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.15.  Japan Nucleic Acid Based Gene Therapy Market

      13.16. Japan Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.17.  Japan Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.18. Japan Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.19. Australia Nucleic Acid Based Gene Therapy Market

      13.20. Australia Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.21. Australia Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.22. Australia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.23. Indonesia Nucleic Acid Based Gene Therapy Market

      13.24. Indonesia Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.25. Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.26. South Korea Nucleic Acid Based Gene Therapy Market

      13.27.  South Korea Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.28. South Korea Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.29. South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14. Western Europe Nucleic Acid Based Gene Therapy Market

      14.1. Western Europe Nucleic Acid Based Gene Therapy Market Overview

      14.1.1. Region Information

      14.1.2. Market Information

      14.1.3. Background Information

      14.1.4. Government Initiatives

      14.1.5. Regulations

      14.1.6. Regulatory Bodies

      14.1.7. Major Associations

      14.1.8. Taxes Levied

      14.1.9. Corporate Tax Structure

      14.1.10. Investments

      14.1.11. Major Companies

      14.2. Western Europe Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.3. Western Europe Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.4. Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.5. Western Europe Nucleic Acid Based Gene Therapy Market: Country Analysis

      14.6. UK Nucleic Acid Based Gene Therapy Market

      14.7. UK Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.8. UK Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.9. UK Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.10. Germany Nucleic Acid Based Gene Therapy Market

      14.11. Germany Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.12. Germany Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.13. Germany Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.14. France Nucleic Acid Based Gene Therapy Market

      14.15. France Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.16. France Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.17. France Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15. Eastern Europe Nucleic Acid Based Gene Therapy Market

      15.1. Eastern Europe Nucleic Acid Based Gene Therapy Market Overview

      15.1.1. Region Information

      15.1.2. Market Information

      15.1.3. Background Information

      15.1.4. Government Initiatives

      15.1.5. Regulations

      15.1.6. Regulatory Bodies

      15.1.7. Major Associations

      15.1.8. Taxes Levied

      15.1.9. Corporate Tax Structure

      15.1.10. Investments

      15.1.11. Major Companies

      15.2. Eastern Europe Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.3. Eastern Europe Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.4. Eastern Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.5. Eastern Europe Nucleic Acid Based Gene Therapy Market: Country Analysis

      15.6. Russia Nucleic Acid Based Gene Therapy Market

      15.7. Russia Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.8. Russia Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.9. Russia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16. North America Nucleic Acid Based Gene Therapy Market

      16.1. North America Nucleic Acid Based Gene Therapy Market Overview

      16.1.1. Region Information

      16.1.2. Market Information

      16.1.3. Background information

      16.1.4. Government Initiatives

      16.1.5. Regulations

      16.1.6. Regulatory Bodies

      16.1.7. Major Associations

      16.1.8. Taxes levied

      16.1.9. Corporate Tax Structure

      16.1.10. Investments

      16.1.11. Major Companies

      16.2. North America Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.3. North America Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      16.4. North America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.5. North America Nucleic Acid Based Gene Therapy Market: Country Analysis

      16.6. USA Nucleic Acid Based Gene Therapy Market

      16.7. USA Nucleic Acid Based Gene Therapy Market Overview

      16.7.1. Country Information

      16.7.2. Market Information

      16.7.3. Background information

      16.7.4. Government Initiatives

      16.7.5. Regulations

      16.7.6. Regulatory Bodies

      16.7.7. Major Associations

      16.7.8. Taxes levied

      16.7.9. Corporate Tax Structure

      16.7.10. Investments

      16.7.11. Major Companies

      16.8. USA Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.9. USA Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      16.10. USA Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17. South America Nucleic Acid Based Gene Therapy Market

      17.1. South America Nucleic Acid Based Gene Therapy Market Overview

      17.1.1. Region Information

      17.1.2. Market Information

      17.1.3. Background Information

      17.1.4. Government Initiatives

      17.1.5. Regulations

      17.1.6. Regulatory Bodies

      17.1.7. Major Associations

      17.1.8. Taxes Levied

      17.1.9. Corporate Tax Structure

      17.1.10. Investments

      17.1.11. Major Companies

      17.2. South America Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.3. South America Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.4. South America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.5. South America Nucleic Acid Based Gene Therapy Market: Country Analysis

      17.6. Brazil Nucleic Acid Based Gene Therapy Market

      17.7. Brazil Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.8. Brazil Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.9. Brazil Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18. Middle East Nucleic Acid Based Gene Therapy Market

      18.1. Middle East Nucleic Acid Based Gene Therapy Market Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. Background information

      18.1.4. Government Initiatives

      18.1.5. Regulations

      18.1.6. Regulatory Bodies

      18.1.7. Major Associations

      18.1.8. Taxes levied

      18.1.9. Corporate Tax Structure

      18.1.10. Investments

      18.1.11. Major Companies

      18.2. Middle East Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.3.Middle East Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.4. Middle East Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19. Africa Nucleic Acid Based Gene Therapy Market

      19.1. Africa Nucleic Acid Based Gene Therapy Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. Background information

      19.1.4. Government Initiatives

      19.1.5. Regulations

      19.1.6. Regulatory Bodies

      19.1.7. Major Associations

      19.1.8. Taxes levied

      19.1.9. Corporate Tax Structure

      19.1.10. Investments

      19.1.11. Major Companies

      19.2. Africa Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.3. Africa Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20. Global Nucleic Acid Based Gene Therapy Market Competitive Landscape

      20.1. Company Profiles

      20.2. Copernicus Therapeutics

      20.2.1. Company Overview

      20.2.2. Products And Services

      20.2.3. Business Strategy

      20.2.4. Financial Overview

      20.3. Moderna Inc.

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. Wave Life Sciences

      20.4.1. Company Overview

      20.4.2. Products And Services

      20.4.3. Business Strategy

      20.4.4. Financial Overview

      20.5. Protagonist Therapeutics

      20.5.1. Company Overview

      20.5.2. Products And Services

      20.5.3. Financial Overview

      20.6. Transgene

      20.6.1. Company Overview

      20.6.2. Products And Services

      20.6.3. Business Strategy

      20.6.4. Financial Overview

      21. Nucleic Acid-based gene Therapy Market Pipeline Analysis

      22. Key Mergers And Acquisitions In The Nucleic Acid-based gene Therapy Market

      22.1. Sanofi Acquired Tidal Therapeutics

      22.2. NeuBase Therapeutics Acquired Vera Therapeutics

      22.3. Astellas Acquired Audentes Therapeutics

      22.4. Roche Acquired Spark Therapeutics Incorporated

      22.5. Vertex Acquired Semma Therapeutics

      22.6. Pfizer Acquired Vivet Therapeutics

      22.7. Vectalys And FlashCell Merge To Create Flash Therapeutics

      22.8. Novartis Acquired AveXis

      22.9. CSL Behring Acquired Calimmune

      23. Global Nucleic Acid Based Gene Therapy Market Opportunities And Strategies

      23.1. Global Nucleic Acid Based Gene Therapy Market In 2025 – Countries Offering Most New Opportunities

      23.2. Global Nucleic Acid Based Gene Therapy Market In 2025 – Segments Offering Most New Opportunities

      23.3. Global Nucleic Acid Based Gene Therapy Market In 2025 – Growth Strategies

      23.3.1. Market Trend Based Strategies

      23.3.2. Competitor Strategies

      24. Global Nucleic Acid Based Gene Therapy Market, Conclusions And Recommendations

      24.1. Conclusions

      24.2. Recommendations

      24.2.1. Product

      24.2.2. Place

      24.2.3. Price

      24.2.4. Promotion

      24.2.5. People

      25. Appendix

      25.1. Market Data Sources

      25.2. Research Methodology

      25.3. Currencies

      25.4. Research Inquiries

      25.5. The Business Research Company

      25.6. Copyright And Disclaimer

    List Of Tables

      Table 1: Global Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 2: Global Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 3: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 4: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 5: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 6: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 7: Global Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 8: Global Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 9: Global Nucleic Acid Based Gene Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 10: Global Nucleic Acid Based Gene Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 11: Global Nucleic Acid Based Gene Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 12: Global Nucleic Acid Based Gene Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 13: Asia-Pacific Healthcare Expenditure, By Country, 2015-2020, $ Billion
    • Table 14: Asia Pacific GDP Per Capita, 2015-2020, $
    • Table 15: Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 16: Asia Pacific Biologics Market, 2015-2025, $ Billion
    • Table 17: Asia-Pacific Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 18: Asia-Pacific Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 19: Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 20: Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 21: China Healthcare Expenditure, 2015-2019, $ Billion
    • Table 22: China GDP Per Capita, 2015-2020, $
    • Table 23: China, Population By Age Group, 2015-2025, Thousands
    • Table 24: Asia Pacific Biologics Market, 2015-2025, $ Billion
    • Table 25: China Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 26: China Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 27: China Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 28: China Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 29: India Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 30: India Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 31: India Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 32: India Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 33: Japan Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 34: Japan Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 35: Japan Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 36: Japan Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 37: Australia Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 38: Australia Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 39: Australia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 40: Australia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 41: Indonesia Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 42: Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 43: Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 44: South Korea Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 45: South Korea Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 46: South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 47: South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 48: Western Europe Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 49: Western Europe GDP Per Capita, 2015-2020, $
    • Table 50: Western Europe, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 51: Western Europe Biologics Market, 2015-2025, $ Billion
    • Table 52: Western Europe Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 53: Western Europe Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 54: Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 55: Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 56: UK Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 57: UK Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 58: UK Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 59: UK Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 60: Germany Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 61: Germany Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 62: Germany Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 63: Germany Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 64: France Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 65: France Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 66: France Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 67: France Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 68: Eastern Europe Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 69: Eastern Europe GDP Per Capita, 2015-2020, $
    • Table 70: Eastern Europe, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 71: Eastern Europe Biologics Market, 2015-2025, $ Billion
    • Table 72: Eastern Europe Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 73: Eastern Europe Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 74: Eastern Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 75: Eastern Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 76: Russia Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 77: Russia Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 78: Russia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 79: Russia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 80: North America Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 81: North America GDP Per Capita, 2015-2020, $
    • Table 82: North America, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 83: North America Biologics Market, 2015-2025, $ Billion
    • Table 84: North America Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 85: North America Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 86: North America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 87: North America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 88: USA Healthcare Expenditure, 2015-2019, $ Billion
    • Table 89: USA GDP Per Capita, 2015-2020, $
    • Table 90: USA, Population By Age Group, 2015-2025, Thousands
    • Table 91: North America Biologics Market, 2015-2025, $ Billion
    • Table 92: USA Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 93: USA Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 94: USA Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 95: USA Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 96: South America Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 97: South America GDP Per Capita, 2015-2020, $
    • Table 98: South America, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 99: South America Biologics Market, 2015-2025, $ Billion
    • Table 100: South America Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 101: South America Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 102: South America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 103: South America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 104: Brazil Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 105: Brazil Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 106: Brazil Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 107: Brazil Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 108: Middle East Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 109: Middle East GDP Per Capita, 2015-2020, $
    • Table 110: Middle East, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 111: Middle East Biologics Market, 2015-2025, $ Billion
    • Table 112: Middle East Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 113: Middle East Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 114: Middle East Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 115: Middle East Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 116: Africa Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 117: Africa GDP Per Capita, 2015-2020, $
    • Table 118: Africa, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 119: Middle East Biologics Market, 2015-2025, $ Billion
    • Table 120: Africa Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 121: Africa Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 122: Africa Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 123: Global Nucleic Acid Based Gene Therapy Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 124: Moderna Inc.  – Financial Performance, 2016 - 2020, $ Billion
    • Table 125: Wave Life Sciences – Financial Performance, 2016 - 2020, $ Million
    • Table 126: Protagonist Therapeutics – Financial Overview, 2017 - 2020, $ Million
    • Table 127: Global Nucleic Acid-based gene Therapy Market, Pipeline Analysis
    • Table 128: Global Nucleic Acid Based Gene Therapy Market Size Gain ($ Million), 2020 – 2025, By Country
    • Table 129: Global Nucleic Acid Based Gene Therapy Market Size Gain ($ Million), Segmentation By Technology, 2020 – 2025
    • Table 130: Global Nucleic Acid Based Gene Therapy Market Size Gain ($ Million), Segmentation By Application, 2020 – 2025
    • Table 131: Global Nucleic Acid Based Gene Therapy Market Size Gain ($ Million), Segmentation By Technology, 2020 – 2025
    • Table 132: Nucleic Acid Based Gene Therapy - Market Data Sources

    List Of Figures

      Figure 1: Global Nucleic Acid-based gene Therapy Market Segmentation By Technology
    • Figure 2: Global Nucleic Acid-based gene Therapy Market Segmentation By Application
    • Figure 3: Global Nucleic Acid-based gene Therapy Market Segmentation By End-User
    • Figure 4: Global Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 5: Global Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 6: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 7: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 8: Global Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 9: Global Nucleic Acid Based Gene Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 10: Global Nucleic Acid Based Gene Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 11: Asia-Pacific Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 12: Asia-Pacific Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 13: Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 14: China Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 15: China Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 16: China Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 17: India Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 18: India Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 19: India Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 20: Japan Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 21: Japan Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 22: Japan Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 23: Australia Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 24: Australia Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 25: Australia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 26: Indonesia Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 27: Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 28: South Korea Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 29: South Korea Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 30: South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 31: Western Europe Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 32: Western Europe Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 33: Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 34: UK Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 35: UK Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 36: UK Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 37: Germany Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 38: Germany Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 39: Germany Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 40: France Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 41: France Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 42: France Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 43: Eastern Europe Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 44: Eastern Europe Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 45: Eastern Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 46: Russia Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 47: Russia Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 48: Russia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 49: North America Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 50: North America Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 51: North America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 52: USA Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 53: USA Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 54: USA Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 55: South America Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 56: South America Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 57: South America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 58: Brazil Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 59: Brazil Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 60: Brazil Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 61: Middle East Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 62: Middle East Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 63: Middle East Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 64: Africa Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 65: Africa Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 66: Global Nucleic Acid Based Gene Therapy Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 67: Moderna Inc. – Financial Performance, 2016 - 2020, $ Billion
    • Figure 68: Wave Life Sciences – Financial Performance, 2016 - 2020, $ Million
    • Figure 69: Protagonist Therapeutics – Financial Overview, 2016 – 2020, $ Million
    Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
    Read More
    Global Gene Therapy Market 2022 – Market Opportunities And Strategies
    Read More
    The Microbiome Market Share, Market Size, And Growth Rate 2022
    Read More
    Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
    Read More
    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
    Read More
    CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Other Oncology Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/Drug Stores, Other Distribution Channels), By Route Of Administration (Oral, Parental, Other Route Of Administration), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2032
    View Report
    Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment) And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Oral Biologics & Biosimilar Drugs Global Market Report 2024 – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies, Other Molecule Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Enzymes Global Market Report 2024 – By Product Type (Asparaginase, Lipase, Protease, Nattokinase, Chitinase, Serratiopeptidase, Collagenase, Ligase, Other Products), By Application (Leukemia, Stomach Disorders, Antitumor, Skin Ulcers, Gaucher Disease, Fabry Disease, Other Applications), By End User (Drug Manufacturers, Hospitals, Private Clinics, Research Laboratories) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Protein Inhibitors Global Market Report 2024 – By Product (Protein Kinase Inhibitors, Monoclonal Antibody, Other Products), By Application (Oncology, Inflammatory Diseases, Other Applications), By Distribution Channel (Hospital Pharmacies, Independent Pharmacies, Online Pharmacies ) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Microbiome Global Market Report 2024 – By Type (Bacteria, Archaea, Viruses, Other Microbiomes), By Product (Therapeutics, Diagnostics), By Technology (Genomics, Proteomics, Metabolomics), By End-Use (Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers, Other Diseases) – Market Size, Trends, And Global Forecast 2024-2033
    View Report